NCT05627232 2026-03-12Tazemetostat and Palbociclib With CPX-351for R/R AMLThomas Jefferson UniversityPhase 1 Recruiting24 enrolled
NCT04915612 2026-02-20Liposomal Cytarabine, Daunorubicin, and Gemtuzumab Ozogamicin for the Treatment of Relapsed Refractory Pediatric Patients With Acute Myeloid LeukemiaM.D. Anderson Cancer CenterPhase 1 Completed1 enrolled